©Author(s) (or their employer(s)) 2026.
World J Crit Care Med. Mar 9, 2026; 15(1): 114620
Published online Mar 9, 2026. doi: 10.5492/wjccm.v15.i1.114620
Published online Mar 9, 2026. doi: 10.5492/wjccm.v15.i1.114620
Table 3 Analysis of vaccines doses and booster doses with post coronavirus disease 2019 diseases, n (%)
| Total number of vaccines | Total | P value | |||||
| 0 | 1 | 2 | 3 and above | ||||
| 11 (1.04) | 103 (9.79) | 122 (11.59) | 816 (77.57) | 1052 (100) | |||
| Ongoing treatment for post COVID-19 complication | Yes | 2 (18.2) | 3 (2.9) | 8 (6.6) | 38 (4.7) | 51 (4.8) | 0.116 |
| Ongoing management for type of complications | Complications developed after COVID-19 | 1 (9.1) | 1 (1.0) | 7 (5.7) | 24 (2.9) | 33 (3.1) | 0.21 |
| Post-COVID management of pre-existing conditions | 1 (9.1) | 2 (1.9) | 1 (0.8) | 14 (1.7) | 18 (1.7) | ||
| Disease developed after COVID-19 | Yes | 2 (18.2) | 12 (11.7) | 19 (15.6) | 117 (14.3) | 150 (14.3) | 0.81 |
- Citation: Jain A, Saraswat P, Sharma A, Sharma V, Jain R. Persistent health complications in COVID-19 hospitalized patients at tertiary care hospital in Western India. World J Crit Care Med 2026; 15(1): 114620
- URL: https://www.wjgnet.com/2220-3141/full/v15/i1/114620.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v15.i1.114620